20 years supporting small and medium enterprises (SMEs) at EMA report
20 years supporting small and medium enterprises (SMEs) at EMA report
20 years supporting small and medium enterprises (SMEs) at EMA report
Product Management Services (PMS) - Implementation of International Organization for Standardization (ISO) standards for the identification of medicinal products (IDMP) in Europe - Chapter 3
Timetable: Marketing authorisation renewal application - ATMP
Timetable: Marketing authorisation renewal application
PSUSA/00002478/202508
PSUSA/00001819/202509
European Medicines Agency (EMA) / European Chemicals Agency (ECHA) joint meeting with industry stakeholders, Online, European Medicines Agency, Amsterdam, the Netherlands, from 9 June 2026, 09:00 (CEST) to 9 June 2026, 12:00 (CEST)
Accelerating Clinical Trials in the EU (ACT EU)
Human medicines European public assessment report (EPAR): Sunosi, solriamfetol, Date of authorisation: 16/01/2020, Revision: 11, Status: Authorised
Human medicines European public assessment report (EPAR): Xenleta, lefamulin, Date of authorisation: 27/07/2020, Revision: 3, Status: Authorised